Clinical Trials Logo

Clinical Trial Summary

DXA scanners are routinely used to assess bone mineral density (BMD) and fracture risk in osteoporosis patients. They provide detailed bone imaging in a low radiation setting. Hologic manufactures scanners that are able to perform high definition instant vertebral fracture assessment (HD-IVA) used to screen at-risk patients for asymptomatic spine fractures instantly and reliably at the same time they are having their yearly BMD. We wish to investigate whether this same proven technology (HD-IVA scan mode) used on femurs (the scan mode is now called SE Femur scans) can be used to screen for atypical fractures of the femur in patients at risk for these debilitating fractures. In this proof of concept study, we propose to examine whether DXA scanners can provide a sensitive low radiation screening method to identify incomplete AFFs in patients with known incomplete AFFs and in patients at risk.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01747304
Study type Observational
Source University Health Network, Toronto
Contact Judite Scher, MSc CCRI
Phone 416-340-4841
Email jscher@uhnresearch.ca
Status Recruiting
Phase
Start date July 2012
Completion date December 2025

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04110795 - Personalizing Osteoporosis Care: Clinical & Genetic Risk Factors for AFFs
Recruiting NCT01747291 - Atypical Fracture Cohort Study
Recruiting NCT02150850 - Quebec Registry for Atypical Femur Fractures
Completed NCT01875458 - Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use